Lista de obras -

A cationic-independent mannose 6-phosphate receptor inhibitor (PXS64) ameliorates kidney fibrosis by inhibiting activation of transforming growth factor-β1

artículo científico publicado en 2015

Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind

scientific article published on 13 April 2019

Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights

artículo científico publicado en 2012

Application of transmission electron tomography for modeling the renal corpuscle.

artículo científico publicado en 2013

Authors' Reply

scientific article published on 09 October 2019

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

artículo científico publicado en 2019

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

artículo científico publicado en 2019

Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies.

artículo científico publicado en 2016

Combined Effects of PPAR γ Agonists and Epidermal Growth Factor Receptor Inhibitors in Human Proximal Tubule Cells

artículo científico publicado en 2013

Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey

artículo científico publicado en 2017

Drug repurposing in kidney disease.

artículo científico publicado en 2018

EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study

scientific article published on 14 April 2020

Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial

artículo científico publicado en 2020

Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2: Subgroup Analysis of the Randomized CREDENCE Trial

scientific article published on 19 November 2020

Effects of Canagliflozin on Cardiovascular, Renal, and Safety Outcomes in Participants With Type 2 Diabetes and Chronic Kidney Disease According to History of Heart Failure: Results From the CREDENCE Trial

artículo científico publicado en 2020

Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?

artículo científico publicado en 2013

Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial

scientific article published on 01 November 2020

Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial

artículo científico publicado en 2013

Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice

artículo científico publicado en 2016

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial

scientific article published on 11 November 2019

Fabry disease deposition mimicking a cardiac tumour and precipitating heart block

artículo científico publicado en 2014

Genetic and environmental risk factors for chronic kidney disease

scientific article published on 20 September 2017

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

artículo científico publicado en 2017

Glucose handling by the kidney ⬇️

artículo científico publicado el 1 de marzo de 2011

Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis

scientific article published on 01 September 2006

Health-Related Quality of Life in People Across the Spectrum of CKD

artículo científico publicado en 2020

How do people with chronic kidney disease value cancer-related quality of life?

artículo científico publicado en 2012

Impact of maternal cigarette smoke exposure on brain and kidney health outcomes in female offspring

artículo científico publicado en 2016

Impact of maternal cigarette smoke exposure on brain inflammation and oxidative stress in male mice offspring

artículo científico publicado en 2016

Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 Study

scientific article published on 11 March 2020

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice

artículo científico publicado en 2020

Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial

artículo científico

Intravenous amino acid therapy for kidney protection in cardiac surgery patients: A pilot randomized controlled trial

scientific article published on 15 December 2018

Linagliptin Limits High Glucose Induced Conversion of Latent to Active TGFß through Interaction with CIM6PR and Limits Renal Tubulointerstitial Fibronectin

artículo científico publicado en 2015

Long non-coding RNAs-towards precision medicine in diabetic kidney disease?

artículo científico publicado en 2016

Maternal Cigarette Smoke Exposure Worsens Neurological Outcomes in Adolescent Offspring with Hypoxic-Ischemic Injury

artículo científico publicado en 2017

Maternal L-Carnitine Supplementation Improves Brain Health in Offspring from Cigarette Smoke Exposed Mothers

artículo científico publicado en 2017

Maternal high-fat diet induces metabolic stress response disorders in offspring hypothalamus.

artículo científico publicado en 2017

Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator).

artículo científico publicado en 2007

Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice

artículo científico publicado en 2016

One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study)

scientific article published on 30 April 2019

Organ protection beyond glycaemic control with SGLT2 inhibitors

artículo científico publicado en 2020

Orthostatic Renal Transplant Compression Following Weight Gain Leading to Acute Kidney Injury

scientific article published on 07 January 2020

Outcomes of Patients with Planned Initiation of Hemodialysis in the IDEAL Trial

artículo científico publicado en 2011

Peritubular ischemia contributes more to tubular damage than proteinuria in immune-mediated glomerulonephritis

artículo científico publicado en 2007

Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected data

scientific article published on 10 November 2020

Prior Cardiovascular Treatments-A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction

artículo científico publicado en 2022

Pure red cell aplasia induced by erythropoiesis-stimulating agents.

artículo científico publicado en 2008

RIPK3 blockade attenuates kidney fibrosis in a folic acid model of renal injury

artículo científico publicado en 2020

RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy

artículo científico publicado en 2020

RIPK3: A New Player in Renal Fibrosis

artículo científico publicado en 2020

Renal epidermal growth factor receptor: Its role in sodium and water homeostasis in diabetic nephropathy ⬇️

artículo científico publicado el 1 de febrero de 2011

Renal glucose transporters: novel targets for hyperglycemia management

artículo científico publicado en 2010

Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial

artículo científico publicado en 2020

Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy

artículo científico publicado en 2014

Research Priorities in CKD: Report of a National Workshop Conducted in Australia

article

Review article: importance of the kidney proximal tubular cells in thiazolidinedione-mediated sodium and water uptake

artículo científico publicado en 2009

Risk Factors for Incident Kidney Disease in Older Adults: an Australian Prospective Population-Based Study

scientific article published on 04 October 2020

Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease

artículo científico publicado en 2013

Role of Toll-like receptors in diabetic nephropathy

artículo científico publicado en 2014

Routine glucose assessment in the emergency department for detecting unrecognised diabetes: a cluster randomised trial

scientific article published on 03 November 2019

SGLT2 inhibitors with and without metformin: a meta-analysis of cardiovascular, kidney and mortality outcomes

artículo científico publicado en 2020

SGLT2 inhibitors with cardiovascular benefits: Transforming clinical care in Type 2 diabetes mellitus.

artículo científico publicado en 2017

SGLT2 inhibitors: New medicines for addressing unmet needs in type 2 diabetes

artículo científico publicado en 2014

SIRT1 overexpression attenuates offspring metabolic and liver disorders as a result of maternal high-fat feeding

artículo científico publicado en 2018

SIRT1 reduction is associated with sex-specific dysregulation of renal lipid metabolism and stress responses in offspring by maternal high-fat diet

artículo científico publicado en 2017

SRT1720 attenuates obesity and insulin resistance but not liver damage in the offspring due to maternal and postnatal high-fat diet consumption

artículo científico publicado en 2018

Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes

artículo científico publicado en 2015

Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review.

artículo científico publicado en 2018

Semicarbazide-sensitive amine oxidase and kidney disease

artículo científico

Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy

scientific article published on 18 June 2020

Short term exendin-4 treatment reduces markers of metabolic disorders in female offspring of obese rat dams.

artículo científico publicado en 2015

Sodium glucose cotransporter 2 and the diabetic kidney

artículo científico

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

artículo científico publicado en 2023

Standardised outcomes in nephrology - Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis.

artículo científico publicado en 2015

Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol.

artículo científico publicado en 2011

The CARI guidelines. Biochemical and haematological targets guidelines. Haemoglobin

scientific article published on 01 October 2005

The CARI guidelines. Nutrition and growth in kidney disease

artículo científico publicado en 2005

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

artículo científico publicado en 2017

The Role of Dipeptidyl Peptidase - 4 Inhibitors in Diabetic Kidney Disease

artículo científico publicado en 2015

The authors reply

artículo científico publicado en 2018

The development of encapsulating peritoneal sclerosis

artículo científico publicado en 2005

The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease

artículo científico publicado en 2017

The impact of maternal cigarette smoke exposure in a rodent model on renal development in the offspring.

artículo científico publicado en 2014

The primary cilia in diabetic kidney disease: A tubulocentric view?

scientific article published on 15 February 2020

The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose

artículo científico publicado en 2014

The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules

artículo científico publicado en 2013

The role of toll-like receptors in diabetic kidney disease

artículo científico publicado en 2017

Therapy Escalation Following an Elevated HbA1c in Adults Aged 45 Years and Older Living With Diabetes in Australia: A Real-world Observational Analysis

scientific article published on 14 September 2020

Treatment strategy of end-stage renal disease related hyperparathyroidism before, during, and after the era of calcimimetics

artículo científico publicado en 2018

Unusual cause of headache following renal transplantation

scientific article published on 14 July 2020

Use of sodium glucose cotransporter-2 inhibitors in Asian patients with type 2 diabetes mellitus and kidney disease: An Asian perspective and expert recommendations

scientific article published on 06 November 2020

Lista de obras de

A cationic-independent mannose 6-phosphate receptor inhibitor (PXS64) ameliorates kidney fibrosis by inhibiting activation of transforming growth factor-β1

Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind

Antibody-mediated pure red cell aplasia in chronic kidney disease patients receiving erythropoiesis-stimulating agents: new insights

Application of transmission electron tomography for modeling the renal corpuscle.

Authors' Reply

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studies.

Combined Effects of PPAR γ Agonists and Epidermal Growth Factor Receptor Inhibitors in Human Proximal Tubule Cells

Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey

Drug repurposing in kidney disease.

EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study

Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial

Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2: Subgroup Analysis of the Randomized CREDENCE Trial

Effects of Canagliflozin on Cardiovascular, Renal, and Safety Outcomes in Participants With Type 2 Diabetes and Chronic Kidney Disease According to History of Heart Failure: Results From the CREDENCE Trial

Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?

Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial

Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial

Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial

Fabry disease deposition mimicking a cardiac tumour and precipitating heart block

Genetic and environmental risk factors for chronic kidney disease

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

Glucose handling by the kidney ⬇️

Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis

Health-Related Quality of Life in People Across the Spectrum of CKD

How do people with chronic kidney disease value cancer-related quality of life?

Impact of maternal cigarette smoke exposure on brain and kidney health outcomes in female offspring

Impact of maternal cigarette smoke exposure on brain inflammation and oxidative stress in male mice offspring

Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 Study

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice

Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial

Intravenous amino acid therapy for kidney protection in cardiac surgery patients: A pilot randomized controlled trial

Linagliptin Limits High Glucose Induced Conversion of Latent to Active TGFß through Interaction with CIM6PR and Limits Renal Tubulointerstitial Fibronectin

Long non-coding RNAs-towards precision medicine in diabetic kidney disease?

Maternal Cigarette Smoke Exposure Worsens Neurological Outcomes in Adolescent Offspring with Hypoxic-Ischemic Injury

Maternal L-Carnitine Supplementation Improves Brain Health in Offspring from Cigarette Smoke Exposed Mothers

Maternal high-fat diet induces metabolic stress response disorders in offspring hypothalamus.

Nanomedicines in the treatment of anemia in renal disease: focus on CERA (Continuous Erythropoietin Receptor Activator).

Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice

One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study)

Organ protection beyond glycaemic control with SGLT2 inhibitors

Orthostatic Renal Transplant Compression Following Weight Gain Leading to Acute Kidney Injury

Outcomes of Patients with Planned Initiation of Hemodialysis in the IDEAL Trial

Peritubular ischemia contributes more to tubular damage than proteinuria in immune-mediated glomerulonephritis

Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected data

Prior Cardiovascular Treatments-A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction

Pure red cell aplasia induced by erythropoiesis-stimulating agents.

RIPK3 blockade attenuates kidney fibrosis in a folic acid model of renal injury

RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy

RIPK3: A New Player in Renal Fibrosis

Renal epidermal growth factor receptor: Its role in sodium and water homeostasis in diabetic nephropathy ⬇️

Renal glucose transporters: novel targets for hyperglycemia management

Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial

Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy

Research Priorities in CKD: Report of a National Workshop Conducted in Australia

Review article: importance of the kidney proximal tubular cells in thiazolidinedione-mediated sodium and water uptake

Risk Factors for Incident Kidney Disease in Older Adults: an Australian Prospective Population-Based Study

Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease

Role of Toll-like receptors in diabetic nephropathy

Routine glucose assessment in the emergency department for detecting unrecognised diabetes: a cluster randomised trial

SGLT2 inhibitors with and without metformin: a meta-analysis of cardiovascular, kidney and mortality outcomes

SGLT2 inhibitors with cardiovascular benefits: Transforming clinical care in Type 2 diabetes mellitus.

SGLT2 inhibitors: New medicines for addressing unmet needs in type 2 diabetes

SIRT1 overexpression attenuates offspring metabolic and liver disorders as a result of maternal high-fat feeding

SIRT1 reduction is associated with sex-specific dysregulation of renal lipid metabolism and stress responses in offspring by maternal high-fat diet

SRT1720 attenuates obesity and insulin resistance but not liver damage in the offspring due to maternal and postnatal high-fat diet consumption

Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes

Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review.

Semicarbazide-sensitive amine oxidase and kidney disease

Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy

Short term exendin-4 treatment reduces markers of metabolic disorders in female offspring of obese rat dams.

Sodium glucose cotransporter 2 and the diabetic kidney

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Standardised outcomes in nephrology - Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis.

Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol.

The CARI guidelines. Biochemical and haematological targets guidelines. Haemoglobin

The CARI guidelines. Nutrition and growth in kidney disease

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics